Free Trial

Oncternal Therapeutics (ONCT) Insider Trading & Ownership

→ Dems have chosen Biden replacement? (From Paradigm Press) (Ad)
Free ONCT Stock Alerts
$8.80
+0.17 (+1.97%)
(As of 05/10/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Oncternal Therapeutics (NASDAQ:ONCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.00%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$102,565.84
Number Of
Insiders Selling
(Last 12 Months)
0
Get ONCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncternal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ONCT Insider Buying and Selling by Quarter

Ad Paradigm Press
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Click here to find out that this 8,788% cryptocurrency is.

Oncternal Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/8/2024Robert James WillsDirectorBuy3,086$8.96$27,650.56  
3/28/2024Robert James WillsDirectorBuy6,914$8.48$58,630.72  
2/23/2024David F HaleDirectorBuy714$9.04$6,454.56  
6/14/2023Gunnar F KaufmannInsiderBuy150$7.20$1,080.00  
6/12/2023Gunnar F KaufmannInsiderBuy1,250$7.00$8,750.00  
(Data available from 1/1/2013 forward)

ONCT Insider Trading Activity - Frequently Asked Questions

Who is on Oncternal Therapeutics's Insider Roster?

The list of insiders at Oncternal Therapeutics includes Chase C Leavitt, David F Hale, Gunnar F Kaufmann, James B Breitmeyer, Richard G Vincent, Robert James Wills, and Salim Yazji. Learn more on insiders at ONCT.

What percentage of Oncternal Therapeutics stock is owned by insiders?

8.00% of Oncternal Therapeutics stock is owned by insiders. Learn more on ONCT's insider holdings.

Which Oncternal Therapeutics insiders have been buying company stock?

The following insiders have purchased ONCT shares in the last 24 months: Chase C Leavitt ($4,350.00), David F Hale ($6,454.56), Gunnar F Kaufmann ($9,830.00), James B Breitmeyer ($29,000.00), Richard G Vincent ($9,000.00), Robert James Wills ($86,281.28), and Salim Yazji ($4,300.00).

How much insider buying is happening at Oncternal Therapeutics?

Insiders have purchased a total of 20,114 ONCT shares in the last 24 months for a total of $149,215.84 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:ONCT) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners
A.I. is a Tidal Wave - Here’s What to Buy
Chaikin Analytics
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
The Crypto 9-5 Escape Plan
Crypto 101 Media
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
Gold Set to EXPLODE!
Gold Safe Exchange
Global crypto currency reset (41 major banks signed up)
Stansberry Research
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press